Skip to main content

Table 1 Study phases and participants

From: Development and validation of an Opioid Attractiveness Scale: a novel measure of the attractiveness of opioid products to potential abusers

Study phase

Participant category

Phase1: Pre-Concept Mapping

Pre-Concept Mapping sample:

• Casual users

• Substance abuse clients

• Pain patients

• Impaired professionals

• Substance abuse experts

Phase 2: Concept Mapping, usability testing

Concept Mapping sample:

• Casual users

• Substance abuse clients

• Pain patients

• Impaired professionals

• Substance abuse experts

 

Usability testing sample:

• Substance abuse clients

• Pain patients

Phase 3: Initial evaluation

Developmental sample:

• Casual users

• Substance abuse clients

Phase 4: Assessment of reliability and validation of scale

Confirmation sample:

• Casual users

• Substance abuse clients

 

Validation sample:

• Substance abuse experts

Definitions of participant categories

Casual users: active recreational users of prescription opioids who were not in treatment

Substance abuse clients: persons in treatment for opioid abuse

Pain patients: patients with a history of opioid misuse

Impaired professionals: persons in the medical field who were current or previous prescription opioid abusers

Substance abuse experts: professional substance abuse counselors experienced in treating opioid addiction